Areas that have been given priority in the Department include molecular pharmacology, cardiac pharmacology, neuropharmacology, cell signalling, and pharmacogenetics. In many of these areas the Department plays a leading role in the international pharmacological community. The research of the Department has consistently been given a very high ranking in the Government’s assessments of research in Universities.
The research projects in the Department are highly interdisciplinary covering the complete range from basic to clinical science. Locally, nationally and internationally the Department plays a pivotal role in a network of collaborations, with basic science collaborations covering engineering, chemistry and biochemistry, as well as physiology and molecular biology. Recently, an interdisciplinary collaboration, including the Humanities, has also been put in place. The Department also has an extensive interaction with industrial partners, including basic instrument development, as well as joint projects with most major global pharmaceutical companies and Biotech companies.
The fundamental challenge for all biomedical research is to validate measurements made in vitro in an in vivo context. The Department is currently developing minimally invasive microendoscope-based imaging methods capable of collecting high resolution images of cells from deep within the intact brain. The establishment of this technique would be a first for Oxford and the UK.
A major strategic initiative between the Department, Medical Sciences Division and the world-renown Oxford Chemistry Department will establish the Oxford Medicinal Chemistry Institute providing a unique environment where pharmacologists and other biomedical scientist can work side by side with chemists to foster drug discovery and develop tools to probe biological systems.
The Pharmacology Department is part of the Medical Sciences Division within the University of Oxford. The Departmental building is located in the centre of the historic City of Oxford.
In vivo/Systems Neuroscience
Drug Discovery/Medicinal Chemistry
Cell Signalling, Molecular Neuroscience and Disease
Professor Nigel Emptage, University Lecturer in Synaptic Pharmacology
Professor Antony Galione, Chair of Pharmacology, Head of Department
Professor Chris Garland, Professor of Vascular Pharmacology
Professor Fran Platt FMedSci, Professor of Biochemistry and Pharmacology
Professor Trevor Sharp, Professor of Neuropharmacology
Professor Rebecca Sitsapesan, Professor of Pharmacology
Professor Derek A Terrar, Professor of Cardiac Electrophysiology
Associate Professor Colin Akerman, University Lecturer in Neuropharmacology
Associate Professor Daniel Anthony, Head of Experimental Neuropathology Laboratory
Associate Professor Grant Churchill, University Lecturer in Chemical Pharmacology
Associate Professor John Parrington, University Lecturer in Cellular and Molecular Pharmacology
Associate Professor Angela Russell, University Lecturer in Medicinal Chemistry
Associate Professor Paolo Tammaro, University Lecturer
Dr Kim Dora, BHF Senior Basic Science Research Fellow
Dr Karri Lämsä, MRC Group Leader
Dr Ming Lei, Senior Research Fellow
Dr Liliana Minichiello, Reader in Cellular and Molecular Neuroscience
Baroness Susan Greenfield, Senior Research Fellow
Dr Jeff Aronson, Department of Primary Health Care
Dr Chas Bountra, Structural Genomics Consortium
Dr Stuart Conway, Chemistry Research Laboratory
Dr Maureen Dale
Professor Len Seymour, Department of Clinical Pharmacology
Professor Steve Watson, University of Birmingham
Professor Andrea Ballabio, Professor of Medical Genetics, Department of Pediatrics, Università degli Studi di Napoli Federico II, Naples, Italy
Professor Garth Cooper, University of Auckland, New Zealand
Professor Cladio Cuello, McGill University, Canada
Professor Leslie Iversen, University of Oxford
Professor Mark Nelson, University of Vermont, Burlington, USA
Professor Barry Potter, University of Bath, UK